ACS Central Science · 2022 · 55 citations · 35 references
Life SciencesGeneticsMolecular BiologyDrug DiscoveryGenome EditingStructural BiologyCrispr-cas SystemsTherapeutic ResistanceClustered Regularly Interspaced Short Palindromic Repeats (Crispr)-based MutagenesisDrug Resistance MutationsMutational ConstraintResistance Mechanism ProfilingResistance-associated MutationsResistance-suppressing MutationsSequence ConservationTernary Complex Formation
Targeted protein degradation (TPD) holds immense promise for drug discovery, but mechanisms of acquired resistance to degraders remain to be fully identified. Here, we used clustered regularly interspaced short palindromic repeats (CRISPR)-suppressor scanning to identify mechanistic classes of drug resistance mutations to molecular glue degraders in GSPT1 and RBM39, neosubstrates targeted by E3 ligase substrate receptors cereblon and DCAF15, respectively. While many mutations directly alter the ternary complex heterodimerization surface, distal resistance sites were also identified. Several distal mutations in RBM39 led to modest decreases in degradation, yet can enable cell survival, underscoring how small differences in degradation can lead to resistance. Integrative analysis of resistance sites across GSPT1 and RBM39 revealed varying levels of sequence conservation and mutational constraint that control the emergence of different resistance mechanisms, highlighting that many regions co-opted by TPD are nonessential. Altogether, our study identifies common resistance mechanisms for molecular glue degraders and outlines a general approach to survey neosubstrate requirements necessary for effective degradation.
35
Identification of a Primary Target of Thalidomide Teratogenicity
Takumi Ito, Hideki Ando, Takayuki Suzuki et al. · Science · 2010 · 2.1K citations
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Krönke, Namrata D. Udeshi, Anupama Narla et al. · Science · 2013 · 1.8K citations · Full text
Medicine, Cell Biology, Oncology +14
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu, Richard E. Middleton, Huahang Sun et al. · Science · 2013 · 1.6K citations · Full text
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
Jan Krönke, Emma C. Fink, Paul W. Hollenbach et al. · Nature · 2015 · 836 citations · Full text
Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
Junwei Shi, Eric Wang, Joseph P. Milazzo et al. · Nature Biotechnology · 2015 · 787 citations · Full text